Correlation between the socio-demographic characteristics and clinical profile with oral manifestations of HIV/AIDS patients
Abstract
Introduction: Human Immunodeficiency Virus (HIV) exhibits the capability to weaken human immune system. The infected subject will later be more susceptible to suffer from opportunistic diseases when the CD4 cell count is lesser than 200 cell/µL. Oral thrush, periodontal disease and xerostomia are common oral manifestations in AIDS patient which initially indicate the presence of HIV infection. This study was aimed to analyse the correlation between the socio-demographic characteristics and clinical profile with oral manifestations of HIV/AIDS patients. Methods: An analytic study with cross-sectional approach was conducted towards the clinical profile and oral manifestation data of HIV/AIDS patients, which obtained from secondary data in the form of medical record. The 55 samples were taken with total sampling technique. Results: The chi-square test found no significant correlation between HIV/AIDS patients socio-demographic and oral manifestations and several significant correlation of the HIV/AIDS patients' clinical profile with the oral manifestation as follows: the total number of CD4 and ARV therapy duration was significantly correlated with the HIV/AIDS patients with candidiasis and oral thrush (p=0.01); while in patients with periodontal disease was only significantly correlated with the total number of CD4 (p=0.02); and no significant correlation found in HIV/AIDS patients with xerostomia. Conclusion: There is no correlation between HIV/AIDS patients socio-demographic and oral manifestations. There is a correlation between several HIV/AIDS patients clinical profile with the oral manifestation. The number of CD4 cells and the ARV therapy duration was correlated with patients with candidiasis and oral thrush, while in patients with periodontal disease on correlated with the number and CD4 cells. HIV/AIDS patients with xerostomia have no correlation with any of their clinical profile.
Keywords
Full Text:
PDFReferences
Yasmin IF, Putra DA, Hakam SA, Fristka L, Lihartanadi J, Biondi M, et al. Knowledge about Reproductive Health among Students in Junior High School 3 Keruak, East Lombok. Sainstek 2020;7(2):077-86. DOI: 10.33476/ms.v7i2.1697
Frimpong P, Kofi EA, Abebrese J, Min SK. Oral Manifestation and Their Correlation to Baseline CD4 Count of HIV/AIDS Patient in Ghana. J Korean Assoc Oral Maxilofac Surg. 2017;43(1):29-36. DOI: 10.5125/jkaoms.
World Health Organization Country Cooperation Strategy Indonesia 2014–2019. Report on HIV-AIDS and Sexually Transmitted Infectious Disease Development. Jakarta: Ministry of Health Indonesia. 2017. p.1–10.
Regulation of Ministry of Health Republic of Indonesia. Jakarta: 2014. p. 18-27.
Widyanti M dan Hutapea H. Total Lymfosit Count (TLC) with CD4 in HIV/AIDS Patients at Kupang. J Teknol Lab. 2019;8(2):16-21. DOI: 10.29238/teknolabjournal.v8i2.189
Kumar V, Abbas A K, Aster J C. Robbins and Contrsn: Pathologic basic of disease 9th ed Philadelphia: Saunders Elsevier; 2015. p. 458-463.
Askynite D, Marulionyte R, Rimkevicus A. Oral manifestations of HIV Disease. Stomatologija, Baltic Dent Maxilofac J. 2015;17(1):22–6.
Dewanti DAR. Manifestasi oral immunie deficiaency virus (HIV)/Acquired Immuno Deficiency Syndrome in Children. J Ked Gi UNEJ. 2010;7(2):79–84.
Hatta I, Firdaus I Wayan AK, Apriasari ML. The Prevalence of Oral Mucosa Disease of Banjarmasin, Soulth Kalimantan. Dentino (Jur. Ked. Gigi). 2018;3(2):211-4. DOI: 10.20527/dentino.v3i2.5380
Gani BA, Soraya C, Sunnati, Nasution AI, Zikri N, Rahadianur R. Changes in artificial salivary pH after its interaction with Candida albicans, Streptococcus mutans, and Aggregatibacter actinomycemcomitans. Cakrawala Dent J. 2013;5(2):542-618. DOI: 10.20473/j.djmkg.v45.i4.p234-238
Rahayunigtyas ED, Setiadhi R. Virus as a Cause of Salivary Gland Diseases. Odonto Dent J. 2019;6(1):37-41. DOI: 10.30659/odj.6.1.37-42
Verma Neha, Patil P, Khana V, Singh V, and Tripathi A. Evaluation of salivary flow rate and gustatory function in HIV positive patients with or without highly active antiretroviral therapy. Eur J Dent. 2017;11(2):226-31. DOI: 10.4103/ejd.ejd_289_16
Han P, Suarez–Durall P, Mulligan R. Dry mouth: A critical topic for older adult patients. Journal of Prosthodontic Reseach. 2015;59(1): 6-19. DOI: 10.1016/j.jpor.2014.11.001.
Lopez-Verdin S. Andrade-Villanueva J, Zamora-Perez AL, Bologna-Molina R, Cervantes-Cabrera JJ, Molina-Frechero N. Difference in salivary flow level xerostomia and flavor alteration in mexican hiv patients who did or did not receive antiretroviral therapy. AIDS Res Treat. 2013;8:10. DOI: 10.1155/2013/613278
Rahayu RP, Widiyanti and Arfijanto M. Genetiv variability of candida albicans in HIV/AIDS patient with and without ARV therapy and non HIV/AIDS. Dent J. 2012;45(1):2-5. DOI: 10.20473/j.djmkg.v45.i1.p28-34
Anglewicz P, Reniers G. HIV Status, Gender, and Marriage Dynamicd Among Adults in Rural Malawi. Wiley. 2014;45(4):5-8. DOI: 10.1111/j.1728-4465.2014.00005.x
Nur'aeny N, Hidayat W, Dewi TS, Herawati E, Indah Suasani Wahyuni IS. Profile of oral candidiasis in oral medicine department of Dr. Hasan Sadikin Hospital Bandung in 2010-2014. Maj Ked Gi Ind 2017;4:6. DOI: 10.22146/majkedgiind.11320
Tesiman J, Sundaru H, Karjadi T, Setiati S. Prevalence and Atopic Predicting Factors in HIV/AIDS Patients. Indonesian J Internal Medic. 2016;3(2):96-8. DOI: 10.7454/jpdi.v3i2.15
Cassone A, Cauda R. Candida and Candidiasis in HIV Infected Patients: where Commensalism Opportunistic Behavior and Frank Pathogrnocoty Lose Their Borders. AIDS. 2012;26(12):1457-72. DOI: 10.1097/QAD.0b013e3283536ba8
Fricke U, Geurtsen W, Staufenbiel I, and Rahman A. Periodontal Status of HIV Infected Patients Undergoing Antiretroviral Therapy Compared to HIV Therapy naivr Patients. Eur J Med Res. 2012; 17(2):2-6. DOI: 10.1186/2047-783X-17-2
Nugraha AP, Triyono EA, Prahasanti C, Sufiawati I, Prasetyo RA, Ernawati DS. The correlation of pathognomonic periodontal manifestation with CD4+ level in people live with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in a Tertiary Hospital, Surabaya, Indonesia. J Int Oral Health 2019;11:137-40. DOI: 10.4103/jioh.jioh_53_19
Toljic Basko. Ageing with HIV – A Periodontal Perspective. New Microbiologica. 2018. 62-64.
Johnson WN. The mouth with HIV/AIDS: marker of disease status and managemet challeges for the dental profesion. Aust Dent J. 2010;55(1):85-102. DOI: 10.1111/j.1834-7819.2010.01203.x.
Valentine J. Impact of periodontal intervention on local inflammation periodontitis and HIV Outcomes. Oral Dis. 2016;22(1):87-97. DOI: 10.1111/odi.12419
Newman, Caranza. Clinical Periodontology. 13rd ed. Philadelphia: Saunders: 2018. p. 492-8.
Matafsi M, Skoura L, Sakellari D. HIV infection and Periodontal Disease: an Overview of The Post HAART Era. Oral Dis. 2011 Jan;17(1):13-25. DOI: 10.1111/j.1601-0825.2010.01727.x
Rusyanti Y. Analysis of Interleukin-8 Level in Aggressive Periodontitis. JAS. 2014;4(3):154-160. DOI: 10.24198/.v4i3.16816.g8113
DOI: https://doi.org/10.24198/pjd.vol33no1.26025
Refbacks
- There are currently no refbacks.
Visitor Stat
Padjadjaran Journal of Dentistry is licensed under Creative Commons Attribution 4.0 International License